Clinical performance of the Elecsys® anti-SARS-CoV-2 combined in an algorithm with two specific anti-IgG immunoassays for the evaluation of the serological response of patients with COVID-19 in a population with a high prevalence of infection.

Xavier Gabaldó Barrios,Simona Iftimie,Anna Hernández-Aguilera,Isabel Pujol,Frederic Ballester,Luis Fernandez,Sara Cladellas,Antoni Castro,Jorge Joven,Jordi Camps,Josep M. Simó

Clinical performance of the Elecsys® anti-SARS-CoV-2 combined in an algorithm with two specific anti-IgG immunoassays for the evaluation of the serological response of patients with COVID-19 in a population with a high prevalence of infection.

2021

Xavier Gabaldó Barrios
Simona Iftimie
Anna Hernández-Aguilera
Isabel Pujol
Frederic Ballester
Luis Fernandez
Sara Cladellas
Antoni Castro
Jorge Joven
Jordi Camps
Josep M. Simó

BackgroundAnti-SARS-CoV-2 antibodies have been used in the study of the immune response in infected patients. However, differences in sensitivity and specificity have been reported, depending on th...

Keywords:

Antibody
Population
Immunology
Immune system
2019 20 coronavirus outbreak
Medicine
Serology
Coronavirus disease 2019
clinical performance
severe acute respiratory syndrome coronavirus 2

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations